Czechia· CZ-0261059
HYLAK FORTE
A milchsäure produzierende organismen product containing escherichia coli metabolites + enterococcus faecalis metabolites + lactobacillus acidophilus metabolites + lactobacillus helveticus metabolites, registered in Czechia by Teva B.V., Haarlem. The same ATC class is registered in 6 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Milchsäure produzierende organismen is registered in 6 of 19 countries.
Countries holding a registration under ATC A07FA01 (milchsäure produzierende organismen), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Milchsäure produzierende organismen · ATC A07FA01
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Norwayprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ESCHERICHIA COLI METABOLITES + ENTEROCOCCUS FAECALIS METABOLITES + LACTOBACILLUS ACIDOPHILUS METABOLITES + LACTOBACILLUS HELVETICUS METABOLITES
- Manufacturer
- Teva B.V., Haarlem
- Country
- Czechia (CZ)
- ATC code
- A07FA01
- ATC class
- Milchsäure produzierende Organismen
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A07FA01
Milchsäure produzierende organismen, as other registers publish it.
- SwitzerlandBioflorin, KapselnOpella Healthcare Switzerland AG
- SwitzerlandBioflorin, KapselnOpella Healthcare Switzerland AG
- CzechiaHYLAK FORTETeva Pharmaceuticals CR, s.r.o., Praha
- CzechiaHYLAK FORTETeva Pharmaceuticals CR, s.r.o., Praha
- CzechiaHYLAK FORTETeva B.V., Haarlem
- CzechiaHYLAK FORTETeva Pharmaceuticals CR, s.r.o., Praha
- CzechiaHYLAK FORTETeva B.V., Haarlem
- CzechiaHYLAK FORTETeva B.V., Haarlem
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/596de49c-82a6-4567-a5ff-7451d2734023 GET /v1/drugs/596de49c-82a6-4567-a5ff-7451d2734023?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "POR SOL",
"source": "sukl",
"strength": null,
"pack_size": "1X100ML",
"substance": "ESCHERICHIA COLI METABOLITES + ENTEROCOCCUS FAECALIS METABOLITES + LACTOBACILLUS ACIDOPHILUS METABOLITES + LACTOBACILLUS HELVETICUS METABOLITES",
"cz_kod_sukl": "0261059",
"product_type": null,
"substance_codes": "15638,15639,15640,15641",
"registration_state": "R",
"registration_number": "49/061/73-S/C"
}See everything about milchsäure produzierende organismen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.